Trazodone for erectile dysfunction: a systematic review and meta‐analysis

Evidence‐based medicine is an important way of allowing the reader to judge clearly whether a treatment has a place in a particular condition, and to see what faults were present in the various trials of its efficacy. It is often rather unsettling to read in a meta‐analysis or in a systematic literature review how poorly constructed many trials are. The authors from Minneapolis have carried out such a study into the use of trazodone in male erectile dysfunction. They draw attention to the poor quality of many of the trials and give their reasons for this observation. They suggest that trazodone may be helpful in men with this condition, possibly at higher doses and in men with psychogenic erectile dysfunction.

[1]  T. Wilt,et al.  Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. , 2002, Archives of internal medicine.

[2]  J. Green,et al.  An investigation of erectile dysfunction in Gwent, Wales , 2001, BJU international.

[3]  J. Sánchez-Cruz,et al.  Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. , 2001, The Journal of urology.

[4]  K. Demyttenaere,et al.  Trazodone: a double-blind, placebo-controlled, randomized study of its effects in patients with erectile dysfunction without major organic findings , 2000, International Journal of Impotence Research.

[5]  H. Sperling,et al.  Affinity of trazodone for human penile α1‐ andα2‐adrenoceptors , 2000, BJU international.

[6]  R. Costabile,et al.  Oral trazodone is not effective therapy for erectile dysfunction: a double-blind, placebo controlled trial. , 1999, The Journal of urology.

[7]  W. Meinhardt,et al.  Trazodone, a double blind trial for treatment of erectile dysfunction , 1997, International Journal of Impotence Research.

[8]  P. Nana-Sinkam,et al.  Outcome analysis of goal directed therapy for impotence. , 1996, The Journal of urology.

[9]  M. Ağargün,et al.  Efficacy of testosterone, trazodone and hypnotic suggestion in the treatment of non-organic male sexual dysfunction. , 1996, British journal of urology.

[10]  J. Oesterling,et al.  Sexual Function of Men Ages 40 to 79 Years: The Olmsted County Study of Urinary Symptoms and Health Status Among Men , 1995, Journal of the American Geriatrics Society.

[11]  W. Steers,et al.  Oral trazodone as empirical therapy for erectile dysfunction: a retrospective review. , 1995, Urology.

[12]  D. Heisey,et al.  The effect of age, ethnicity and geographical location on impotence and quality of life. , 1995, British journal of urology.

[13]  M. Clarke,et al.  Identifying relevant studies for systematic reviews , 1995, BMJ.

[14]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[15]  K. Dickersin,et al.  Systematic Reviews: Identifying relevant studies for systematic reviews , 1994 .

[16]  F. Montorsi,et al.  Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. , 1994, Urology.

[17]  D. Erol,et al.  The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction. , 1994, The Journal of urology.

[18]  I. Eardley New oral therapies for the treatment of erectile dysfunction. , 1998, British journal of urology.

[19]  H A Feldman,et al.  Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. , 1994, The Journal of urology.

[20]  NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. , 1993, JAMA.